한국인 조현병 환자와 도파민 D2 수용체 유전자 다형성과의 관련연구

키워드

참고문헌 (32)

1. Serretti A, "The socio-economical burden of schizophrenia: a simulation of costoffset of early intervention program in Italy", Eur Psychiatry, 24, pp.11~16 (2009)
2. McGuffin P, "Genetic basis of schizophrenia", Lancet, 346, pp.678~682 (1995)
3. Tsuang MT, "The genetics of schizophrenia. Current knowledge and future directions", Schizophr Res, 4, pp.157~171 (1991)
4. Carlsson A, "The current status of the dopamine hypothesis of schizophrenia", Neuropsychopharmacology, 1, pp.179~186 (1988)
5. Sobell JL, "Novel association approach for determining the genetic predisposition to schizophrenia: case-control resource and testing of a candidate gene", Am J Med Genet, 48, pp.28~35 (1993)
6. Comings DE, "The dopamine D2 receptor locus as a modifying gene in neuropsychiatric disorders", JAMA, 266, pp.1793~1800 (1991)
7. Kapur S, "Half a century of antipsychotics and still a central role for dopamine D2 receptors", Prog Neuropsychopharmacol Biol Psychiatry, 27, pp.1081~1090 (2003)
8. Dubertret C, "A genetic schizophrenia-susceptibility region located between the ANKK1 and DRD2 genes", Prog Neuropsychopharmacol Biol Psychiatry, 34, pp.492~499 (2010)
9. Grandy DK, "The human dopamine D2 receptor gene is located on chromosome 11 at q22-q23 and identifies a TaqI RFLP", Am J Hum Genet, 45, pp.778~785 (1989)
10. Hauge XY, "Detection and characterization of additional DNA polymorphisms in the dopamine D2 receptor gene", Genomics, 10, pp.527~530 (1991)
11. Parsian A, "A new TaqI RFLP within intron 2 of human dopamine D2 receptor gene (DRD2)", Nucleic Acids Res, 19, pp.6977~ (1991)
12. Lee HS, "Distribution of the TaqI polymorphism of the dopamine D2 receptor in a Korean schizophrenic population", J Korean Neuropsychiatric Assoc, 34, pp.1641~1651 (1995)
13. 강철중, "정신분열병환자에서 Taq I A 도파민 D2 수용체 다형성과 항정신병약물의 치료반응과의 연관", 생물정신의학, 12(2), pp.29~35 (2005), 대한생물정신의학회
14. 이소영, "뚜렛증후군과 만성 틱장애 그리고 도파민 D2 수용체 유전자와의 연합 연구", 생물정신의학, 13(4), pp.295~302 (2006), 대한생물정신의학회
15. 최태영, "알코올 의존 환자의 금단 증상에 영향을 미치는 도파민계 (DRD2, DAT, COMT) 유전자 다형성", 생물정신의학, 13(3), pp.178~188 (2006), 대한생물정신의학회
16. Lim SW, "Association between panic disorder and dopamine D2 receptor TaqI A polymorphism", Anxiety and Mood, 2, pp.45~49 (2006)
17. 김범조, "한국인 사회공포증 환자에서 도파민 D2 수용체 TaqI A 유전자 다형성:예비연구", 생물정신의학, 14(2), pp.106~114 (2007), 대한생물정신의학회
18. Lee SY, "D2 dopamine receptor (DRD2) gene polymorphism and combat-related posttraumatic stress disorder in vietnam veterans", Anxiety and Mood, 4, pp.142~147 (2008)
19. Castiglione CM, "Evolution of haplotypes at the DRD2 locus", Am J Hum Genet, 57, pp.1445~1456 (1995)
20. Kidd KK, "DRD2 haplotypes containing the TaqI A1 allele: implications for alcoholism research", Alcohol Clin Exp Res, 20, pp.697~705 (1996)
21. Dubertret C, "Association and excess of transmission of a DRD2 haplotype in a sample of French schizophrenic patients", Schizophr Res, 49, pp.203~212 (2001)
22. Dubertret C, "The 3’ region of the DRD2 gene is involved in genetic susceptibility to schizophrenia", Schizophr Res, 67, pp.75~85 (2004)
23. Golimbet VE, "Analysis of the linkage of the Taq1A and Taq1B loci of the dopamine D2 receptor gene with schizophrenia in patients and their siblings", Neurosci Behav Physiol, 33, pp.223~225 (2003)
24. Behravan J, "Linkage and association of DRD2 gene TaqI polymorphism with schizophrenia in an Iranian population", Arch Iran Med, 11, pp.252~256 (2008)
25. Hwang R, "Association study of 12 polymorphisms spanning the dopamine D(2) receptor gene and clozapine treatment response in two treatment refractory", intolerant populations, 2005, pp.181, 179~187
26. Vijayan NN, "Association of dopamine receptor polymorphisms with schizophrenia and antipsychotic response in a South Indian population", Behav Brain Funct, 3, pp.34~ (2007)
27. Kaiser R, "Relationship between adverse effects of antipsychotic treatment and dopamine D(2) receptor polymorphisms in patients with schizophrenia", Mol Psychiatry, 7, pp.695~705 (2002)
28. Wu SN, "Association of DRD2 polymorphisms and chlorpromazine-induced extrapyramidal syndrome in Chinese schizophrenic patients", Acta Pharmacol Sin, 27, pp.966~970 (2006)
29. Xing Q, "The relationship between the therapeutic response to risperidone and the dopamine D2 receptor polymorphism in Chinese schizophrenia patients", Int J Neuropsychopharmacol, 10, pp.631~637 (2007)
30. Lafuente A, "Polymorphism of dopamine D2 receptor (TaqIA, TaqIB, and-141C Ins", Del) and dopamine degradation enzyme (COMT G158A, A-278G) genes and extrapyramidal symptoms in patients with schizophrenia and bipolar disorders, 2008, pp.161, 131~141
31. Young-Min Park, "No Evidence for an Association between Dopamine D2 Receptor Polymorphisms and Tardive Dyskinesia in Korean Schizophrenia Patients", PSYCHIATRY INVESTIGATION, 8(1), pp.49~54 (2011), 대한신경정신의학회
32. Kyu Young Lee, "Associations between DRDs and schizophrenia in a Korean population: multi-stage association analyses", Experimental and Molecular Medicine, 43(1), pp.44~52 (2011), 생화학분자생물학회

관련 논문AI추천